Early cardiovascular involvement in Chronic Obstructive Pulmonary Disease

Monaldi Archives for Chest Disease - Pulmonary Series

Volumn 71, Issue 2, 2009, Pages 59-65

  Malerba, Mario ^a   Romanelli, G ^a  

^a UNIVERSITY OF BRESCIA   (Italy)

Author keywords

Chronic obstructive pulmonary disease (COPD); Early cardiovascular involvement

Indexed keywords

AGING; ATHEROSCLEROSIS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CHRONIC OBSTRUCTIVE LUNG DISEASE; HEART VENTRICLE FUNCTION; HUMAN; HYPOXIA; INFLAMMATION; OXIDATIVE STRESS; PATHOGENESIS; REVIEW;

EID: 69249184857     PISSN: 11220643     EISSN: 2465101X     Source Type: Journal    
DOI: 10.4081/monaldi.2009.362     Document Type: Review

References (60)

1. Pauwels RA, Buist AS, Calverley PM, et al. Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) workshop summary. Am J Respir Crit Care Med 2001; 163: 1256-1276 (Pubitemid 32378468)
2. Chen JC, Mannino DM. Worldwide epidemiology of chronic obstructive pulmonary disease. Curr Opin Pulm Med 1999; 5: 93-99
3. Sin DD, Man SFP. Chronic obstructive pulmonary disease: a novel risk factor for cardiovascular disease. Can J Physiol Pharmacol 2005; 83: 8-13. (Pubitemid 40754770)
4. Maclay D, McAllister DA, MacNee W. Cardiovascular risk in chronic obstructive pulmonary disease. Respirology 2007; 12: 634-641. (Pubitemid 47414891)
5. Sin DD, Man SFP. Chronic Obstructive Pulmonary Disease as a risk factor for cardiovascular morbidity and mortality. Proc Am Thorac Soc 2005; 2: 8-11. (Pubitemid 40562956)
6. Gan WQ, Man SF, Sin DD, et al. Association between chronic obstuctive pulmonary disease and systemic inflammation: a systematic review and a meta-analysis. Thorax 2004; 59: 574-580.
7. Yanbaeva DG, Dentener MA, Creutzberg EC, et al. Systemic effects of smoking. Chest 2007; 131: 1557-1566.
8. Gan WQ, Man SF, Sin DD. The interactions between cigarette smoking and reduced lung function on systemic inflammation. Chest 2005; 27: 558-564.
9. Ridker PM. Clinical application of C-reactive protein for cardiovascular disease detection and prevention. Circulation 2003; 107: 363-369. (Pubitemid 36158034)
10. Ross R. Atherosclerosis - an inflammatory disease. N Engl J Med 1999; 340: 115-126.
11. Lusis AJ. Atherosclerosis. Nature 2000; 407: 233-241.
12. Pasceri V, Willerson JT, Yet ETH. Direct proinflammatory effect of C-reactive protein on human endothelial cells. Circulation 2000; 102: 2165-2168. (Pubitemid 30808000)
13. Zwaka TP, Hombach V, Torzewski J. C-reactive protein-mediated low density lipoprotein uptake by macrophages: implications for atherosclerosis. Circulation 2001; 103: 1194-1197. (Pubitemid 32221339)
14. Danesh J, Collins R, Appleby P, et al. Association of fibrinogen, C-reactive protein, albumin, or leukocyte count with coronary heart disease: meta-analyses of prospective studies. JAMA 1998; 279: 1477-1482. (Pubitemid 28228207)
15. Wedzicha JT, Seemungal TA, MacCallum PK, et al. Acute exacerbations of chronic obstructive pulmonary disease are accompanied by elevations of plasma fibrinogen and serum IL6 levels. Thromb Haemost 2000; 84: 210-215.
16. Mancini GBJ, Etminan M, Zhang B, Levesque LE, et al. Reduction of morbidity and mortality by statins, angiotensin-converting enzyme inhibitors, and angiotensin receptor blockers in patients with Chronic Obstructive Pulmonary Disease. J Am Coll Cardiol 2006; 47: 2554-2560. (Pubitemid 43866389)
17. Calverly PMA, Anderson JA, Celli B, et al. Salmeterol and Fluticasone Propionate and Survival in Chronic Obstructive Pulmonary Disease. N Engl J Med 2007; 356: 775-789. (Pubitemid 46294610)
18. Rahman I. Oxidative stress in pathogenesis of chronic obstructive pulmonary disease: cellular and molecular mechanisms. Cell Biochem Biophys 2005; 43: 167-188 (Pubitemid 41095282)
19. Rahman I. Oxidative stress and gene trascription in asthma and chronic obstructive pulmonary disease: antioxidant terapeutic targets. Curr Drug Inflamm Allergy 2002; 1: 219-315.
20. Rahman I. The role of oxidative stress in the pathogenesis of COPD: implication for therapy. Treat Respir Med 2005 4: 175-200. (Pubitemid 41018366)
21. Kirkham P, Rahman I. Oxidative stress in asthma and COPD: antioxidants as a therapeutic strategy. Pharmacol Ther 2006; 111: 476-494 (Pubitemid 43832007)
22. Ito K, Barnes PJ. COPD as a disease of accelerating lung aging. Chest 2009; 135: 173-180
23. Giordano FJ. Oxygen, oxidative stress, hypoxia and heart failure. J Clin Invest 2005; 115: 500-508. (Pubitemid 40322219)
24. Huang Y, et al. Cardiac myocyte-specific HIF-1alpha deletion alters vascularization, energy availability, calcium flux, and contractility in the normoxic heart. FASEB J 2004; 18: 1138-1140. (Pubitemid 39561549)
25. Davies KJ. Oxidative stress: the paradox of aerobic life. Biochem Soc Symp 1995; 61: 1-31.
26. Carmeliet P, et al. Role of HIF-1alpha in hypoxia-mediated apoptosis, cell proliferation and tumour angiogenesis. Nature 1998; 394: 485-490.
27. Khatri JJ, Johnson C, Magid R, et al. Vascular oxidant stress enhances progression and angiogenesis of experimental atheroma. Circulation 2004; 109: 520-525. (Pubitemid 38168516)
28. Sin DD, Anthonisen NR, Soriano JB, Agusti AG. Mortality in COPD: role of comorbidities. Eur Respir J 2006; 28: 1245-1257.
29. Sin DD, Wu L, Man SF. The relationship between reduced lung function and cardiovascular mortality: a population-based study and a systematic review of the literature. Chest 2005; 127: 1952-1959. (Pubitemid 46260082)
30. Anthonisen NR, Connet JE, Enright PL, et al. Hospitalization and mortality in the Lung Health Study. Am J Respir Crit Care Med 2002: 333-339. (Pubitemid 34864422)
31. Le Jemtel TH, Padeletti M, Jelic S. Diagnostic and therapeutic challenges in patients with coexistent chronic obstructive pulmonary disease and chronic heart failure. J Am Coll Cardiol 2007; 49: 171-180. (Pubitemid 46054390)
32. Rutten FH, Moons KG, Cramer MJ, et al. Recognising heart failure in elderly patients with stable chronic obstructive pulmonary disease in primary care: cross sectional diagnostic study. BMJ 2005; 331: 1379-1382.
33. Janssens JP, Pache JC, Nicod LP. Physiological changes in respiratory function associated with ageing. Eur Respir J 1999; 13: 197-205. (Pubitemid 29079244)
34. O'Rourke M. Arterial stiffness, systolic blood pressure, and logical treatment of arterial hypertension. Hypertension 1990; 15: 339-347. (Pubitemid 20137587)
35. Vogelmeier C, Bals R. Chronic obstructive pulmonary disease and premature aging. Am J Respir Crit Care Med 2007; 175: 1217-1218. (Pubitemid 46905744)
36. Fletcher C, Peto R. The natural history of chronic airflow obstruction. BMJ 1977; 1: 1645-1648. (Pubitemid 8124466)
37. Teramoto S, Ishii M. Aging, the aging lung, and senile emphysema are different. Am J Respir Crit Care Med 2007; 175: 197-198. (Pubitemid 46115094)
38. Chan SR, Blackburn EH. Telomeres and telomerase. Philos Trans R Soc Lond B Biol Sci 2004; 359: 109-121.
39. Saretzki G, Von Zglinicki T. Replicative aging, telomeres, and oxidative stress. Ann NY Acad Sci 2002; 959: 24-29. (Pubitemid 34457548)
40. Aviv A. Telomeres and human somatic fitness. J Gerontol A Biol Sci Med Sci 2006; 61: 871-873.
41. Nyunoya T, Monick MM, Klingelhutz A, Yarovinsky TO, Cagley JR, Hunninghake GW. Cigarette smoke induces cellular senescence. Am J Respir Cell Mol Biol 2006; 35: 681-688. (Pubitemid 44901857)
42. van der Harst P, van Veldhuisen DJ, Samani NJ. Expanding the concept of telomere dysfunction in cardiovascular disease. Arterioscler Thromb Vasc Biol 2008; 28: 807-808.
43. Brouilette SW, Moore JS, et al. Telomere length, risk of coronary heart disease, and statin treatment in the West of Scotland Primary Prevention Study: a nested case-control study. Lancet 2007; 369: 107-114.
44. Aviv H, Khan MY, Skurnick J, et al. Age dependent aneuploidy and telomere length of the human vascular endothelium. Atherosclerosis 2001; 159: 281-287. (Pubitemid 33127241)
45. Ogami M, Ikura Y, Ohsawa M, et al. Telomere shortening in human coronary artery diseases. Arterioscler Thromb Vasc Biol 2004; 24: 546-550. (Pubitemid 38326151)
46. Minamino T, Kourembanas S. Mechanisms of telomerase induction during vascular smooth muscle cell proliferation. Circ Res 2001; 2001: 237-243. (Pubitemid 34132681)
47. Tsirpanlis G. Cellular senescence, cardiovascular risk, and CKD: a review of established and hypothetical interconnections. Am J Kidney Dis 2008; 2008: 131-144. (Pubitemid 350296521)
48. Agusti A, Soriano JB. COPD as a systemic disease. COPD 2008; 5: 133-138.
49. Sabit R, Bolton CE, Edwards PH, et al. Arterial stiffness and osteoporosis in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2007; 175: 1259-1265 (Pubitemid 46905751)
50. Tillin T, Chambers J, Malik I, Coady E, et al. Measurement of pulse wave velocity: site matters. J Hypertens 2007; 25: 383-389 (Pubitemid 46071936)
51. Rutten FH, Cramer MJ, Lammers JW, Grobbee DE, Hoes AW. Heart failure and chronic obstructive pulmonary disease: An ignored combination? Eur J Heart Fail 2006; 8: 706-711.
52. McCullough PA, Hollander JE, Nowak RM, et al. Uncovering heart failure in patients with a history of pulmonary disease: rationale for the early use of B-type natriuretic peptide in the emergency department. Acad Emerg Med 2003; 10: 198-204. (Pubitemid 36292619)
53. Remes J, Miettinen H, Reunanen A, Pyörälä K. Validity of clinical diagnosis of heart failure in primary health care. Eur Heart J 1991; 12: 315-321
54. Rao BS, Cohn KE, Eldridge FL, Hancock EW. Left ventricular failure secondary to chronic pulmonary disease. Am J Med 1968; 45: 229-241
55. Gehlbach BK, Geppert E. The pulmonary manifestations of left heart failure. Chest 2004; 125: 669-682 (Pubitemid 38223649)
56. Harrigan RA, Jones K. ABC of clinical electrocardiography. Conditions affecting the right side of the heart. BMJ 2002; 324: 1201-1204
57. Morrison LK, Harrison A, Krishnaswamy P, Kazanegra R, Clopton P, Maisel A. Utility of a rapid B-natriuretic peptide assay in differentiating congestive heart failure from lung disease in patients presenting with dyspnea. J Am Coll Cardiol 2002; 39: 202-209 (Pubitemid 34084622)
58. Lang CC, Coutie WJ, Struthers AD, Dhillon DP, Winter JH, Lipworth BJ. Elevated levels of brain natriuretic peptide in acute hypoxaemic chronic obstructive pulmonary disease. Clin Sci (Lond) 1992; 83: 529-533
59. Boussuges A, Pinet C, Molenat F, et al. Left atrial and ventricular filling in chronic obstructive pulmonary disease. An echocardiographic and Doppler study. Am J Respir Crit Care Med 2000; 162: 670-675 (Pubitemid 30647217)
60. Pennell DJ, Sechtem UP, Higgins CB, et al. Clinical indications for cardiovascular magnetic resonance (CMR): consensus panel report. Eur Heart J 2004; 25: 1940-1965.